具有适应激活的疗法模型用于建模癌症存活率
1AbbVie, Inc., North Chicago, IL, USA.
Statistical methods in medical research
|February 1, 2024
概括
我们为癌症生存率分析引入了一种新的治愈率模型,比现有方法提供更高的准确性,特别是当假设被违反时. 这种自适应模型改善了结肠癌和乳腺癌研究的推断.
科学领域:
- 生物统计学 生物统计学
- 生存分析的分析.
- 癌症研究 癌症研究
背景情况:
- 治愈率模型对于分析癌症存活率数据至关重要,特别是对于长期存活的疾病.
- 现有的模型,如第一次和最后一次激活,在模型错误规范下可能缺乏稳定性.
- 对结肠癌和三阴性乳腺癌存活率数据的分析需要先进的建模技术.
研究的目的:
- 提出一种新的灵活类型的治愈率模型,通过适应激活参数进行索引.
- 为拟议的模型类建立随机排序和识别结果.
- 在模型错误规范的情况下,证明拟议模型的性能优于现有方法.
主要方法:
- 开发一个新的治愈率模型类,具有自适应激活参数和函数.
- 关于激活参数的随机排序属性的数学建立.
- 为拟议的模型类推导出两个可识别结果.
- 与现有的第一次和最后一次激活模型进行比较分析.
主要成果:
- 建议的治愈率模型的类别在激活参数中以随机顺序排列.
- 对于新型号类别,确定了两个关键的识别结果.
- 根据错误规范,自适应激活模型与第一次和最后一次激活模型相比,证明了更合适的推断.
- 该模型已成功应用于结肠癌和三阴性乳腺癌数据.
结论:
- 拟议的自适应治愈率模型为癌症存活率分析提供了一个灵活而强大的替代方案.
- 这种方法提供了更好的推断,特别是当标准模型假设不满足时.
- 该模型的适用性在现实癌症数据集中得到证实,涉及治疗性相互作用和瘤异质性.
相关概念视频
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:20Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:15Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K